Magainin-2 [G3,18K; F5W; A15K; E19K; M21Nle]
General Information
DRACP ID DRACP01969
Peptide Name Magainin-2 [G3,18K; F5W; A15K; E19K; M21Nle]
Sequence GIKKWLHSAKKFGKKFVKKIXNS
Sequence Length 23
UniProt ID P11006
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
PANC-1 | Pancreatic ductal adenocarcinoma | Carcinoma | EC50=9.1±3 µM(pH=7.4) | WST-1 assay | 24 h | 1 |
Hemolytic Activity Human kidney-derived GM cells: EC50=7.6±2.1 µM(pH=6); EC50=25.6±4.5 µM(pH=7.4)
Normal (non-cancerous) Cytotoxicity HEK293: EC50=15.7±1.8 µM(pH=7.4)
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification X=Nle
Chiral L
Physicochemical Information
Formula C123H200N34O25
Absent amino acids CDEMPQRTY
Common amino acids K
Mass 305774
Pl 11.65
Basic residues 9
Acidic residues 0
Hydrophobic residues 8
Net charge 9
Boman Index -3172
Hydrophobicity -73.04
Aliphatic Index 67.83
Half Life
/
Extinction Coefficient cystines 5500
Absorbance 280nm 250
Polar residues 5
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 31161686
Title Endowment of pH responsivity to anticancer peptides by introducing 2,3-diaminopropionic acid residues
Year 2019
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID DBAASPS_13418